Nitric oxide and atrial natriuretic peptide (ANP) 1 activate soluble or particulate guanylyl cyclases, respectively. The cGMP produced by these cyclases has multiple effectors within the cell, including cGMP-gated channels, cGMP-regulated phosphodiesterases, and cGMP-dependent protein kinases (cGKs). cGK I (including ␣-and -splice variants) and cGK II have been identified in mammalian cells. The cGK I studied here is a major mediator of the nitric oxide/cGMP signal transduction pathway in several tissues (1); and recently, the functional role of cGK I in relaxation of smooth muscle, inhibition of Ca 2ϩ transients, and inhibition of platelet adhesion and aggregation was consolidated by data from cGK I knockout mice (2, 3). Furthermore, cGK I is present in only certain endothelial cells, and only these respond to cGMP with a reduction in thrombininduced calcium transients and paracellular permeability (4, 5).The relationship between cGK I substrate phosphorylation and cellular function is still an emerging field and is the subject of this investigation. One extensively studied substrate of cGK I is the vasodilator-stimulated phosphoprotein (VASP), originally discovered in human platelets (6), but a substrate of cGK I in many cells, including endothelial cells (1, 5). In platelets, both cAMP-and cGMP-dependent phosphorylation of VASP closely correlate with inhibition of agonist-induced aggregation and in particular with inhibition of fibrinogen receptor (integrin ␣ IIb  3 ) activation (7). In knockout mice lacking endogenous VASP, cGMP-mediated inhibition of platelet aggregation was reduced, and agonist-induced platelet activation was enhanced (8, 9). Similarly, knockout mice lacking endogenous cGK I also displayed defective cGMP-mediated inhibition of platelet aggregation (3). cGMP-dependent phosphorylation of VASP (only Ser 157 was measurable at that time), but not cAMPdependent phosphorylation of VASP, disappeared from the platelets of cGK I knockout mice (3) as well as from cGK I-deficient platelets from chronic myelocytic leukemia patients (10) and from endothelial cells that lost cGK I in culture (5), clear evidence that cGMP-dependent phosphorylation of VASP is mediated by cGK and not by activation of cAK. In contrast, cAMP-dependent phosphorylation of VASP is mediated by cAK.In cells studied so far, VASP has been shown to be localized at highly dynamic membrane regions, focal adhesions, and cell-cell contacts and in a periodic pattern along stress fibers (11,12). Recently, VASP-related proteins (now designated as members of the Ena/VASP protein family), which share some structural and functional characteristics with VASP, were identified (13,14). Demonstration of VASP interaction with other proteins present at several intracellular sites suggested a role for VASP in cytoskeletal function. The N-terminal Ena/ VASP homology 1 (EVH1) domain of the Ena/VASP protein family was shown to interact with a proline-rich FP 4 -containing motif present in the focal adhesion proteins zyxin and vinculin (15) and also pr...